NCT06591754

Brief Summary

The primary objective of this study is to evaluate the feasibility and acceptability of a 25-week combined group and individual therapy program using Intensive Short-Term Dynamic Psychotherapy (ISTDP) for patients diagnosed with personality disorders. The secondary objective is to investigate preliminary effects of the treatment in terms of reducing symtoms of depression, anxiety and emotion regulation difficulties.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Sep 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Sep 2024Dec 2027

First Submitted

Initial submission to the registry

September 8, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

September 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

3.3 years

First QC Date

September 8, 2024

Last Update Submit

September 10, 2024

Conditions

Keywords

Personality disorderISTDPIntensive Short-Term Dynamic Psychotherapy

Outcome Measures

Primary Outcomes (8)

  • Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews

    Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews

    Immediately after treatment completion

  • Depression symtoms

    Depression symtoms will be measured with Patient Health Questionnaire (PHQ-9; (Kroenke et al., 2001)

    Baseline, weekly throughout treatment, immediately after treatment completion and 6-month follow-up

  • Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)

    Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)

    Immediately after treatment completion (25 weeks)

  • Adverse events related to the treatment

    Adverse events related to the treatment

    From start of treatment up to. 6 month follow up.

  • Number of individual sessions attended during the treatment

    Number of individual sessions attended during the treatment

    Throughout the treatment period, up to 25 weeks

  • Number of group sessions attended during the treatment

    Number of group sessions attended during the treatment

    Throughout the treatment period, up to 25 weeks

  • Number of dropouts

    Number of dropouts

    Throughout the treatment period, up to 25 weeks

  • Total number of sessions attended during the treatment

    Total number of sessions attended during the treatment

    Throughout the treatment period, up to 25 weeks

Secondary Outcomes (10)

  • Fear of negative emotions

    Change from baseline to post-treatment (25 weeks) and follow up 6 months after treatment.

  • Anxiety symtoms

    Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.

  • Emotions regulation difficulties

    Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.

  • Severity of personality disorder

    Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.

  • Symtoms of Borderline Personality disorder

    Change from baseline to immediately after treatment completion (25 weeks) and follow up 6 months after treatment.

  • +5 more secondary outcomes

Study Arms (1)

ISTDP

EXPERIMENTAL

ISTDP combined group- and individual therapy

Behavioral: ISTDP

Interventions

ISTDPBEHAVIORAL

Both the individual therapy and the group therapy is based on ISTDP (Intensive Short-Term Dynamic Psychotherapy), an affect-focused psychodynamic therapy method. The therapy focus on the relationship between feelings, anxiety and dysfunctional emotion regulation (i.e. defenses). The purpose is to increase the capacity of anxiety regulation in the patient and to help the patient identify the dysfunctional patterns developed to avoid internal stress and then gradually approach previously warded of feelings. The individual therapy consists of 25 weekly sessions. The group treatment consists of 18 weekly sessions and is structured in three phases. Phase one: Psychoeducation about anxiety and exercises in anxiety regulation. Phase two: patients takes turn to observe their own anxiety and defenses together with a therapist. Phase three: Every session two patients will work with a chosen problem and identify defenses, anxiety and feelings together with a therapist in front of the group.

ISTDP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Personality disorder diagnosis (Clinical assessment using STIP-5) Speaks Swedish fluently

You may not qualify if:

  • Autism or intellectual disability Borderline, antisocial or narcissistic personality disorder diagnosis Need for interpreter Urgent social misery Psychotic disorder High suicidality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affektiva, ångest och traumaprogrammet, Psykiatri Sydväst

Stockholm, 14157, Sweden

Location

MeSH Terms

Conditions

Personality Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD and licensed psychologist

Study Record Dates

First Submitted

September 8, 2024

First Posted

September 19, 2024

Study Start

September 9, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

The raw data collected in the study can be made available on a group level given that the request comply with Swedish and EU laws regulating protection of identifiable data.

Locations